- Home
- PYXS vs YMAT Comparison
PYXS vs YMAT Comparison
Compare PYXS & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- YMAT
- Stock Information
- Founded
- PYXS 2018
- YMAT 1970
- Country
- PYXS United States
- YMAT Taiwan
- Employees
- PYXS N/A
- YMAT N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- YMAT Recreational Games/Products/Toys
- Sector
- PYXS Health Care
- YMAT Consumer Discretionary
- Exchange
- PYXS Nasdaq
- YMAT Nasdaq
- Market Cap
- PYXS 75.0M
- YMAT 76.4M
- IPO Year
- PYXS 2021
- YMAT 2025
- Fundamental
- Price
- PYXS $1.34
- YMAT $5.59
- Analyst Decision
- PYXS Buy
- YMAT
- Analyst Count
- PYXS 4
- YMAT 0
- Target Price
- PYXS $8.67
- YMAT N/A
- AVG Volume (30 Days)
- PYXS 443.9K
- YMAT 808.5K
- Earning Date
- PYXS 08-14-2025
- YMAT 01-01-0001
- Dividend Yield
- PYXS N/A
- YMAT N/A
- EPS Growth
- PYXS N/A
- YMAT N/A
- EPS
- PYXS N/A
- YMAT 0.07
- Revenue
- PYXS $2,820,000.00
- YMAT $17,563,985.00
- Revenue This Year
- PYXS N/A
- YMAT N/A
- Revenue Next Year
- PYXS N/A
- YMAT N/A
- P/E Ratio
- PYXS N/A
- YMAT $79.80
- Revenue Growth
- PYXS N/A
- YMAT N/A
- 52 Week Low
- PYXS $0.83
- YMAT $3.80
- 52 Week High
- PYXS $5.39
- YMAT $6.45
- Technical
- Relative Strength Index (RSI)
- PYXS 65.01
- YMAT N/A
- Support Level
- PYXS $1.14
- YMAT N/A
- Resistance Level
- PYXS $1.38
- YMAT N/A
- Average True Range (ATR)
- PYXS 0.09
- YMAT 0.00
- MACD
- PYXS 0.03
- YMAT 0.00
- Stochastic Oscillator
- PYXS 80.43
- YMAT 0.00
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.